Concepedia

Trason Thode

TT

Statistics

Publications

7

Citations

213

H-Index

7

Active since

2016

Affiliations

Translational Genomics Research Institute(Current)

Huntsman Cancer Institute

University of Utah

City of Hope

UNC Lineberger Comprehensive Cancer Center

Trason Thode is an author at Translational Genomics Research Institute specializing in life sciences, oncology, and tumor suppressor genes.

ORCID

Publications per year

2016–2022

7

Publications

7

The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer

Raffaella Soldi, Tithi Ghosh, Alexis Weston et al. · PLoS ONE · 2020 · 82 citations · Full text

, , +16

Reversible lysine-specific demethylase 1 antagonist HCI-2509 inhibits growth and decreases c-MYC in castration- and docetaxel-resistant prostate cancer cells

Sumati Gupta, Alexis Weston, Jared Bearrs et al. · Prostate Cancer and Prostatic Diseases · 2016 · 47 citations · Full text

, , +16

Long-term hepatitis B virus infection of rhesus macaques requires suppression of host immunity

Sreya Biswas, Lauren N. Rust, Jochen M. Wettengel et al. · Nature Communications · 2022 · 20 citations · Full text

, , +17

Abstract 3077: Preclinical studies of SR-8314, a highly selective ENPP1 inhibitor and an activator of STING pathway

Alexis Weston, Trason Thode, Rubén M. Muñoz et al. · Cancer Research · 2019 · 19 citations

, , +14

The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer

Raffaella Soldi, Tithi Ghosh, Alexis Weston et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 19 citations · Full text

, , +16

1–5 of 7